Viewing data from:

DOBUTAMINE HYDROCHLORIDE

ANDA

DOBUTAMINE HYDROCHLORIDE | A216131 | SLATE RUN PHARMACEUTICALS LLC

1 strength0 unique patents0 unique exclusivities

API Supply Chain5 active DMFs7 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

CHEMWERTH INCDOBUTAMINE HYDROCHLORIDE

DMF 88561990

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPADOBUTAMINE HYDROCHLORIDE

DMF 97621992

SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHDOBUTAMINE HYDROCHLORIDE

DMF 110231994

HAINAN POLY PHARM CO LTDDOBUTAMINE HYDROCHLORIDE USP

DMF 352172020

ARAGEN LIFE SCIENCES LTDDOBUTAMINE HYDROCHLORIDE

DMF 426022025

ABBOTT LABORATORIESInactiveDOBUTAMINE HYDROCHLORIDE

DMF 85891990

RAYLO CHEMICALSInactiveDOBUTAMINE HYDROCHLORIDE

DMF 90241991

SUMIKA FINE CHEMICALS CO LTDInactiveDOBUTAMINE HYDROCHLORIDE

DMF 93691991

HUHTAMAKI OY LEIRAS PHARMACEUTICALSInactiveDOBUTAMINE HYDROCHLORIDE

DMF 98881992

EGIS PHARMACEUTICALS PRIVATE LTDInactiveDOBUTAMINE HYDROCHLORIDE

DMF 100971993

CHEMSYN SCIENCE LABORATORIESInactiveDOBUTAMINE HYDROCHLORIDE

DMF 102961993

IROTEC LABORATORIESInactiveDOBUTAMINE HYDROCHLORIDE

DMF 107061994

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 12.5MG BASE/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Dec 21, 2022

No patent or exclusivity listings for this strength.